The first demonstration of inhibiting tumor growth by targeting VEGF-A in vivo was achieved with the murine anti-human VEGF-A monoclonal antibody A.4.6.1, in nude mice transplanted with human tumors [78]. Here, VEGFA is linked to neoplasm.